CONUT could be a noninvasive prognostic indicator that useful for predicting long-term survival in GI cancer patients after surgery.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: